Preoperative Dexamethasone to Improve Quality of Recovery After Laparoscopic Bariatric Surgery
NCT05752734 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2023-09-21
Summary
In the obese patient, adequate pain relief in the postoperative period is an important parameter that affects patient comfort and hospital stay. Increasing patient comfort and recovery quality can be achieved by avoiding undesirable effects such as nausea and vomiting, as well as analgesia. In our study, our aim is to evaluate the effect of dexamethasone added to multimodal analgesia on postoperative patient comfort in the obese patient group with a 40-item scale.
Conditions
- Anesthesia
- Analgesia
- Acute Pain
Interventions
- DRUG
-
Group D
Patients who received 8 mg dexamethasone before bariatric surgery will be included in this group. Multimodal analgesia protocol is applied to all patients undergoing bariatric surgery in our clinic. According to this protocol, patients are administered iv tenoxicam 20mg, tramadol 100mg after induction of general anesthesia, and iv morphine (0.05mg/kg/IBW) intraoperatively. Postoperative analgesia: iv paracetamol 1gr every 8 hours and iv pca of 0,4mg/ml morphine (the bolus dose is 1mg, the lock-in time of 15 minutes, the 4-hour limit is adjusted to be 40% of the calculated total dose). In cases where rescue analgesia is required (VAS score ≥3) 0.5 mg/kg tramadol is administered to patients. For postoperative nausea and vomiting prophylaxis, patients are routinely administered ondansetron 4 mg IV 20 minutes before extubation.
- DRUG
-
Group C
Patients not administered dexamethasone will be included in this group. Multimodal analgesia protocol is applied to all patients undergoing bariatric surgery in our clinic. According to this protocol, patients are administered iv tenoxicam 20mg, tramadol 100mg after induction of general anesthesia, and iv morphine (0.05mg/kg/IBW) intraoperatively. Postoperative analgesia: iv paracetamol 1gr every 8 hours and iv pca of 0,4mg/ml morphine (the bolus dose is 1mg, the lock-in time of 15 minutes, the 4-hour limit is adjusted to be 40% of the calculated total dose). In cases where rescue analgesia is required (VAS score ≥3) 0.5 mg/kg tramadol is administered to patients. For postoperative nausea and vomiting prophylaxis, patients are routinely administered ondansetron 4 mg IV 20 minutes before extubation.
Sponsors & Collaborators
-
Ondokuz Mayıs University
lead OTHER
Principal Investigators
-
Yasemin Burcu Üstün · Ondokuz Mayıs University
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-02
- Primary Completion
- 2023-06-01
- Completion
- 2023-06-10
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.
NCT03809182 ·Status: COMPLETED ·Phase: PHASE4
-
The EFFICIENCY of FASCIAL PLANE BLOCKS in BARIATRIC SURGERY
NCT05284695 ·Status: COMPLETED
-
The Effect of Early Mobilization on Pain Level After Laparoscopic Bariatric Surgery
NCT05961345 ·Status: COMPLETED ·Phase: NA
-
Perioperative Systemic Lidocaine for Enhanced Bowel Recovery After Bariatric Surgery
NCT02607488 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
One-Year Outcomes After Conversion Bariatric Surgery
NCT07345429 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations
NCT02843698 ·Status: COMPLETED ·Phase: PHASE4
-
Opioid-sparing Versus Sevoflurane Anesthesia on Early Postoperative Hypoventilation in Laparoscopic Bariatric Surgery
NCT05962671 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Preoperative Hypocaloric Hyperproteinic Lipid Restricting Diet on Bariatric Surgery
NCT05529199 ·Status: RECRUITING
-
Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery
NCT05286008 ·Status: UNKNOWN ·Phase: NA
-
Anesthetics and Cerebral Oxygenation in LSG
NCT03946657 ·Status: COMPLETED ·Phase: PHASE4
-
Low-Volume Oral Carbohydrate Feeding in Bariatric Surgery: Effects on PONV and Recovery
NCT07018440 ·Status: COMPLETED ·Phase: NA
-
Incretin Hormone Antagonism After Bariatric Surgery
NCT03950245 ·Status: COMPLETED ·Phase: NA
-
Perioperative Nutrition in Gastric Bypass Surgery
NCT00549237 ·Status: COMPLETED ·Phase: NA
-
Diaphragm Functions in Bariatric Surgeries
NCT04828408 ·Status: COMPLETED
-
Establishment of a Classification System and Postoperative Risk Warning Model for Patients Undergoing Bariatric Metabolic Surgery for Severe Obesity
NCT07093502 ·Status: RECRUITING
-
Comparison of the Effect of Traditional Method and Eras Protocol in Obesity Surgery
NCT05790317 ·Status: COMPLETED ·Phase: NA
-
Preoperative Exercise Test and Postoperative Intensive Care Unit Need in Bariatric Surgery
NCT03419104 ·Status: UNKNOWN ·Phase: NA
-
Multi-Strategy Intervention for Anesthesia Care of Obese Patients A Factorial Randomized Controlled Trial
NCT05016076 ·Status: WITHDRAWN ·Phase: NA
-
Low-Flow Anesthesia and Perioperative Atelectasis in Laparoscopic Bariatric Surgery
NCT07041567 ·Status: COMPLETED ·Phase: NA
-
The Effect of Mobile Health-Education Application on Healthy Lifestyle Behaviors in Patients Planned for Bariatric Surgery
NCT05428059 ·Status: SUSPENDED ·Phase: NA
-
Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)
NCT04599504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Antibiotic Prophylaxis in Metabolic Bariatric Surgery
NCT06510452 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Does Pre-operative Patients' Education Facilitates Emergence of Anesthesia Following Bariatric Surgery?
NCT01946763 ·Status: UNKNOWN ·Phase: NA
-
Prospective Study of Hormone Levels After Bariatric Surgery
NCT00627315 ·Status: COMPLETED
-
Predictors of Anesthesia Complications in Patients Undergoing Bariatric Surgery
NCT06981793 ·Status: COMPLETED